Several posters will be presented at the upcoming @theaacr.bsky.social AM that feature cohorts created by @su2c.bsky.social funded teams. Check out the following abstracts for more information: 2713, 6473, 1045, 7742, and 5908. Congrats to all the presenters! #AACR26
April 7, 2026 at 2:51 PM
Several posters will be presented at the upcoming @theaacr.bsky.social AM that feature cohorts created by @su2c.bsky.social funded teams. Check out the following abstracts for more information: 2713, 6473, 1045, 7742, and 5908. Congrats to all the presenters! #AACR26
It was a couple of busy months for our lab! Antonia presented our work on Tumor Treating Fields in #GBM #glioblastoma at @theaacr.bsky.social Special Conference on Brain Cancer and we also presented it at #AACR26! Grateful to @theaacr.bsky.social @novocure.bsky.social for supporting our work!
April 24, 2026 at 9:33 PM
It was a couple of busy months for our lab! Antonia presented our work on Tumor Treating Fields in #GBM #glioblastoma at @theaacr.bsky.social Special Conference on Brain Cancer and we also presented it at #AACR26! Grateful to @theaacr.bsky.social @novocure.bsky.social for supporting our work!
Does adherence to oral cancer therapy matter? Yes, says our Dr. @vanmorrismd.bsky.social.
At #AACR26, he presented strategies for improving outcomes for standard therapies and clinical trials for colorectal cancer. #EndCancer
At #AACR26, he presented strategies for improving outcomes for standard therapies and clinical trials for colorectal cancer. #EndCancer
April 20, 2026 at 9:21 PM
Does adherence to oral cancer therapy matter? Yes, says our Dr. @vanmorrismd.bsky.social.
At #AACR26, he presented strategies for improving outcomes for standard therapies and clinical trials for colorectal cancer. #EndCancer
At #AACR26, he presented strategies for improving outcomes for standard therapies and clinical trials for colorectal cancer. #EndCancer
"Cancers with CCNE1, FBXW7 and PPP2R1A alterations represent areas of unmet need, with no specific standard of care options," says Dr. Timothy Yap while presenting results from the Phase 1 MYTHIC trial at #AACR26. (1/2)
April 19, 2026 at 10:07 PM
"Cancers with CCNE1, FBXW7 and PPP2R1A alterations represent areas of unmet need, with no specific standard of care options," says Dr. Timothy Yap while presenting results from the Phase 1 MYTHIC trial at #AACR26. (1/2)
Congratulations to our Dr. Jim Allison on receiving this prestigious award. Learn more about the honor: bit.ly/4tUgrzb #AACR26 #EndCancer
April 19, 2026 at 9:50 PM
Congratulations to our Dr. Jim Allison on receiving this prestigious award. Learn more about the honor: bit.ly/4tUgrzb #AACR26 #EndCancer
Congratulations to our Dr. Natalie Vokes on receiving an
@theaacr.bsky.social Trailblazer Cancer Research Grant, announced at this morning's #AACR26 opening ceremony.
This grant will support her research into CDKN2A/MTAP-deleted non-small cell lung cancer. #EndCancer
@theaacr.bsky.social Trailblazer Cancer Research Grant, announced at this morning's #AACR26 opening ceremony.
This grant will support her research into CDKN2A/MTAP-deleted non-small cell lung cancer. #EndCancer
April 19, 2026 at 7:44 PM
Congratulations to our Dr. Natalie Vokes on receiving an
@theaacr.bsky.social Trailblazer Cancer Research Grant, announced at this morning's #AACR26 opening ceremony.
This grant will support her research into CDKN2A/MTAP-deleted non-small cell lung cancer. #EndCancer
@theaacr.bsky.social Trailblazer Cancer Research Grant, announced at this morning's #AACR26 opening ceremony.
This grant will support her research into CDKN2A/MTAP-deleted non-small cell lung cancer. #EndCancer
Based on the initial results from the CheckMate 77T trial,
@fda.govapproved perioperative nivolumab for the treatment of resectable non-small cell lung cancer in 2024.
At #AACR26, Dr. Tina Cascone presented additional findings derived from biomarker analyses. (1/2)
@fda.govapproved perioperative nivolumab for the treatment of resectable non-small cell lung cancer in 2024.
At #AACR26, Dr. Tina Cascone presented additional findings derived from biomarker analyses. (1/2)
April 18, 2026 at 9:27 PM
Based on the initial results from the CheckMate 77T trial,
@fda.govapproved perioperative nivolumab for the treatment of resectable non-small cell lung cancer in 2024.
At #AACR26, Dr. Tina Cascone presented additional findings derived from biomarker analyses. (1/2)
@fda.govapproved perioperative nivolumab for the treatment of resectable non-small cell lung cancer in 2024.
At #AACR26, Dr. Tina Cascone presented additional findings derived from biomarker analyses. (1/2)
Dr. Ying Yuan develops methods and tools for data analysis. At #AACR26, he led a workshop on using Bayesian designs in early-phase clinical trials.
"The Bayesian Optimal Phase 2 design offers a highly-efficient, unified framework for futility and toxicity monitoring," he shared. #EndCancer
"The Bayesian Optimal Phase 2 design offers a highly-efficient, unified framework for futility and toxicity monitoring," he shared. #EndCancer
April 18, 2026 at 8:46 PM
Dr. Ying Yuan develops methods and tools for data analysis. At #AACR26, he led a workshop on using Bayesian designs in early-phase clinical trials.
"The Bayesian Optimal Phase 2 design offers a highly-efficient, unified framework for futility and toxicity monitoring," he shared. #EndCancer
"The Bayesian Optimal Phase 2 design offers a highly-efficient, unified framework for futility and toxicity monitoring," he shared. #EndCancer
Dr. Moran Amit will present results from a clinical trial at #AACR26 that examined immunotherapy injections for patients with oral lesions.
One of the trial participants shares more on the main treatment side effect she experienced - elation: spr.ly/63324B6fCXI #OncSky #EndCancer
One of the trial participants shares more on the main treatment side effect she experienced - elation: spr.ly/63324B6fCXI #OncSky #EndCancer
Two-time tongue cancer survivor: Why I support research at UT MD Anderson
When Jessica Lutterman was told she needed a third oral surgery for a possible tongue cancer recurrence, she turned to UT MD Anderson. Find out why an immunotherapy clinical trial here inspired her to support our research
spr.ly
April 17, 2026 at 8:14 PM
Dr. Moran Amit will present results from a clinical trial at #AACR26 that examined immunotherapy injections for patients with oral lesions.
One of the trial participants shares more on the main treatment side effect she experienced - elation: spr.ly/63324B6fCXI #OncSky #EndCancer
One of the trial participants shares more on the main treatment side effect she experienced - elation: spr.ly/63324B6fCXI #OncSky #EndCancer
From preserving quality of life for patients with oral cancer, to harnessing the power of AI for better lung cancer treatment outcomes, researchers from UT MD Anderson will be highlighting their cutting-edge work at #AACR26.
Learn more: spr.ly/6010B6fCnA @theaacr.bsky.social #OncSky #EndCancer
Learn more: spr.ly/6010B6fCnA @theaacr.bsky.social #OncSky #EndCancer
Top 3 UT MD Anderson abstracts at AACR 2026
Albert Koong, M.D., Ph.D., shares three abstracts that will be shared by UT MD Anderson researchers at the 2026 annual meeting of the American Association for Cancer Research. These breakthroughs in discovery science and translational research will move cancer therapies further for our patients.
spr.ly
April 17, 2026 at 5:16 PM
From preserving quality of life for patients with oral cancer, to harnessing the power of AI for better lung cancer treatment outcomes, researchers from UT MD Anderson will be highlighting their cutting-edge work at #AACR26.
Learn more: spr.ly/6010B6fCnA @theaacr.bsky.social #OncSky #EndCancer
Learn more: spr.ly/6010B6fCnA @theaacr.bsky.social #OncSky #EndCancer
Cancer research is moving fast, bringing better treatments to patients sooner.
In this Cancerwise podcast episode, learn how new technologies and multimodal data are advancing precision oncology and improving cancer care.
Listen: spr.ly/63329B6fDj9
#AACR26 #EndCancer
In this Cancerwise podcast episode, learn how new technologies and multimodal data are advancing precision oncology and improving cancer care.
Listen: spr.ly/63329B6fDj9
#AACR26 #EndCancer
Cancerwise Podcast
UT MD Anderson’s Cancerwise podcast features insights from our experts on cancer diagnosis and treatment, research breakthroughs, and prevention, as well as stories from survivors and caregivers who’ve faced cancer firsthand.
spr.ly
April 16, 2026 at 4:08 PM
Cancer research is moving fast, bringing better treatments to patients sooner.
In this Cancerwise podcast episode, learn how new technologies and multimodal data are advancing precision oncology and improving cancer care.
Listen: spr.ly/63329B6fDj9
#AACR26 #EndCancer
In this Cancerwise podcast episode, learn how new technologies and multimodal data are advancing precision oncology and improving cancer care.
Listen: spr.ly/63329B6fDj9
#AACR26 #EndCancer
Our Jennifer Wargo, M.D., has been elected to the 2026 @theaacr.bsky.social class of fellows in recognition of her pioneering work to define interactions between the microbiome, cancer biology and treatment response.
More about this prestigious honor: spr.ly/6012B6NHmG #AACR26 #OncSky #EndCancer
More about this prestigious honor: spr.ly/6012B6NHmG #AACR26 #OncSky #EndCancer
AACR: Jennifer Wargo, M.D., elected Fellow of the AACR Academy
Jennifer Wargo, M.D., professor of Surgical Oncology and Genomic Medicine at The University of Texas MD Anderson Cancer Center, has been elected to the 2026 class of Fellows of the American Association for Cancer Research (AACR) Academy in recognition of her pioneering work to define interactions between the microbiome, cancer biology and treatment response.
spr.ly
April 14, 2026 at 2:30 PM
Our Jennifer Wargo, M.D., has been elected to the 2026 @theaacr.bsky.social class of fellows in recognition of her pioneering work to define interactions between the microbiome, cancer biology and treatment response.
More about this prestigious honor: spr.ly/6012B6NHmG #AACR26 #OncSky #EndCancer
More about this prestigious honor: spr.ly/6012B6NHmG #AACR26 #OncSky #EndCancer
#AACR26 | Pancreatic cancer: a new family of immune cells discovered in “super-responders”. Learn more about this novel research led by Dr. Marc Hilmi, medical oncologist at the Institut Curie ⏩ institut-curie.org/news/optimiz...
April 23, 2026 at 1:07 PM
#AACR26 | Pancreatic cancer: a new family of immune cells discovered in “super-responders”. Learn more about this novel research led by Dr. Marc Hilmi, medical oncologist at the Institut Curie ⏩ institut-curie.org/news/optimiz...
At the #AACR26, Institut Curie presented a very promising results of new "optimized" CAR-T in primary oculocerebral lymphoma ⏩ institut-curie.org/news/optimiz...
April 23, 2026 at 8:07 AM
At the #AACR26, Institut Curie presented a very promising results of new "optimized" CAR-T in primary oculocerebral lymphoma ⏩ institut-curie.org/news/optimiz...
#AACR26 | Oncogenetics: A New Approach to Managing Genetic Predispositions to Colon Cancer presented by Dr. Keltouma Driouch shows direct and major impact on the follow-up and monitoring of patients.
⏩ institut-curie.org/news/optimiz...
⏩ institut-curie.org/news/optimiz...
April 21, 2026 at 2:09 PM
#AACR26 | Oncogenetics: A New Approach to Managing Genetic Predispositions to Colon Cancer presented by Dr. Keltouma Driouch shows direct and major impact on the follow-up and monitoring of patients.
⏩ institut-curie.org/news/optimiz...
⏩ institut-curie.org/news/optimiz...
#AACR26 | Dr. Gurdrun Schleiermacher presented new results showing how liquid biopsies can track tumor evolution and improve Care for Children with High-Risk Neuroblastoma.
More infos ⏩ institut-curie.org/news/optimiz...
More infos ⏩ institut-curie.org/news/optimiz...
April 21, 2026 at 12:32 PM
#AACR26 | Dr. Gurdrun Schleiermacher presented new results showing how liquid biopsies can track tumor evolution and improve Care for Children with High-Risk Neuroblastoma.
More infos ⏩ institut-curie.org/news/optimiz...
More infos ⏩ institut-curie.org/news/optimiz...
Come to @ddiannae.bsky.social poster today at 9 am! #AACR26
Our BCCB group is at #AACR26! @dfcibreastonc.bsky.social
Led by @ddiannae.bsky.social, and working with Daniel Abravanel and I, we present the multi-omics + evolutionary analysis of the Metastatic Breast Cancer project (MBCproject).
Session PO.MCB08.05
Wed April 22 2026, 9 AM-12 PM
Poster 7265
Led by @ddiannae.bsky.social, and working with Daniel Abravanel and I, we present the multi-omics + evolutionary analysis of the Metastatic Breast Cancer project (MBCproject).
Session PO.MCB08.05
Wed April 22 2026, 9 AM-12 PM
Poster 7265
Abstract 7265: MBCproject: multi-omic profiling of metastatic breast cancer evolution through patient-partnered research
Abstract. The Metastatic Breast Cancer project (MBCproject) is a patient-partnered research study that has collected clinical, genomic, and survey data through online enrollment. The cohort includes w...
doi.org
April 22, 2026 at 2:11 PM
Come to @ddiannae.bsky.social poster today at 9 am! #AACR26
Our BCCB group is at #AACR26! @dfcibreastonc.bsky.social
Led by @ddiannae.bsky.social, and working with Daniel Abravanel and I, we present the multi-omics + evolutionary analysis of the Metastatic Breast Cancer project (MBCproject).
Session PO.MCB08.05
Wed April 22 2026, 9 AM-12 PM
Poster 7265
Led by @ddiannae.bsky.social, and working with Daniel Abravanel and I, we present the multi-omics + evolutionary analysis of the Metastatic Breast Cancer project (MBCproject).
Session PO.MCB08.05
Wed April 22 2026, 9 AM-12 PM
Poster 7265
Abstract 7265: MBCproject: multi-omic profiling of metastatic breast cancer evolution through patient-partnered research
Abstract. The Metastatic Breast Cancer project (MBCproject) is a patient-partnered research study that has collected clinical, genomic, and survey data through online enrollment. The cohort includes w...
doi.org
April 16, 2026 at 4:11 PM
Our BCCB group is at #AACR26! @dfcibreastonc.bsky.social
Led by @ddiannae.bsky.social, and working with Daniel Abravanel and I, we present the multi-omics + evolutionary analysis of the Metastatic Breast Cancer project (MBCproject).
Session PO.MCB08.05
Wed April 22 2026, 9 AM-12 PM
Poster 7265
Led by @ddiannae.bsky.social, and working with Daniel Abravanel and I, we present the multi-omics + evolutionary analysis of the Metastatic Breast Cancer project (MBCproject).
Session PO.MCB08.05
Wed April 22 2026, 9 AM-12 PM
Poster 7265
Just wrapped up an incredible #AACR26 in San Diego! 🧬✨ Inspiring science & so proud to have presented our poster with the amazing @campilati.bsky.social, co-supervised with @laurent-puig.bsky.social from @crcordeliers.bsky.social
@siriccarpem.bsky.social. Check out our preprint 👉 bit.ly/YAP-Rev 🙌
@siriccarpem.bsky.social. Check out our preprint 👉 bit.ly/YAP-Rev 🙌
April 23, 2026 at 7:39 PM
Just wrapped up an incredible #AACR26 in San Diego! 🧬✨ Inspiring science & so proud to have presented our poster with the amazing @campilati.bsky.social, co-supervised with @laurent-puig.bsky.social from @crcordeliers.bsky.social
@siriccarpem.bsky.social. Check out our preprint 👉 bit.ly/YAP-Rev 🙌
@siriccarpem.bsky.social. Check out our preprint 👉 bit.ly/YAP-Rev 🙌
Xueyao is presenting another project at #AACR26 (a GWAS of AML) Tuesday afternoon (LB387). Stop by to learn more our npj breast cancer paper and her ongoing research on interpretable AI and other topics! 2/2
April 20, 2026 at 2:08 AM
Xueyao is presenting another project at #AACR26 (a GWAS of AML) Tuesday afternoon (LB387). Stop by to learn more our npj breast cancer paper and her ongoing research on interpretable AI and other topics! 2/2
Also, if you’re around Saturday morning, sign up for the #AACR Runners for Research 5k. Always a good time, and–no offence to the Windy City–the weather in San Diego this year will probably be better than last. #AACR26 #Runners4Research donate.aacr.org/events/773
AACR Runners for Research 5K Run/Walk 2026I'm fundraising for American Association for Cancer Research and cancer research!
AACR Runners for Research 5K Run/Walk 2026Event landing page for AACR Runners for Research 5K Run/Walk 2026
donate.aacr.org
April 13, 2026 at 5:15 PM
Also, if you’re around Saturday morning, sign up for the #AACR Runners for Research 5k. Always a good time, and–no offence to the Windy City–the weather in San Diego this year will probably be better than last. #AACR26 #Runners4Research donate.aacr.org/events/773
Looking forward to #AACR26 in San Diego in less than a week! Check out these presentations from our team, including the largest ever GWAS of breast cancer & AML and a hot-off-the-presses study of mutational patterns in triple-negative breast cancer.
April 13, 2026 at 5:15 PM
Looking forward to #AACR26 in San Diego in less than a week! Check out these presentations from our team, including the largest ever GWAS of breast cancer & AML and a hot-off-the-presses study of mutational patterns in triple-negative breast cancer.
🎉 Celebrating the 2026 Brooks Scholar Award recipients!
We’re proud to recognize:
🌟 Alexander Arnuk, Ph.D.
🌟 Cristina Baquero Mayo, Ph.D.
🌟 James Miller, Ph.D.
The fellowship supports postdocs advancing work at the intersection of #aging and #cancer: www.jax.org/news-and-ins...
#AACR26 #Oncosky
We’re proud to recognize:
🌟 Alexander Arnuk, Ph.D.
🌟 Cristina Baquero Mayo, Ph.D.
🌟 James Miller, Ph.D.
The fellowship supports postdocs advancing work at the intersection of #aging and #cancer: www.jax.org/news-and-ins...
#AACR26 #Oncosky
Spotlight on the 2026 Brooks Scholars
The Brooks Scholar Award supports innovative research projects to unravel the connection between cancer and aging
www.jax.org
April 24, 2026 at 12:13 PM
🎉 Celebrating the 2026 Brooks Scholar Award recipients!
We’re proud to recognize:
🌟 Alexander Arnuk, Ph.D.
🌟 Cristina Baquero Mayo, Ph.D.
🌟 James Miller, Ph.D.
The fellowship supports postdocs advancing work at the intersection of #aging and #cancer: www.jax.org/news-and-ins...
#AACR26 #Oncosky
We’re proud to recognize:
🌟 Alexander Arnuk, Ph.D.
🌟 Cristina Baquero Mayo, Ph.D.
🌟 James Miller, Ph.D.
The fellowship supports postdocs advancing work at the intersection of #aging and #cancer: www.jax.org/news-and-ins...
#AACR26 #Oncosky
🔬 Build practical skills in cancer modeling at @jax.org’s Cancer Techniques Workshop.
Expert-led lectures, hands-on training and personalized mentoring in the lab.
📍 Bar Harbor, ME | 📅 Sept. 10 – 16
Space is limited. 🔗 www.jax.org/education-an...
#AACR26
Expert-led lectures, hands-on training and personalized mentoring in the lab.
📍 Bar Harbor, ME | 📅 Sept. 10 – 16
Space is limited. 🔗 www.jax.org/education-an...
#AACR26
April 23, 2026 at 12:05 PM
🔬 Build practical skills in cancer modeling at @jax.org’s Cancer Techniques Workshop.
Expert-led lectures, hands-on training and personalized mentoring in the lab.
📍 Bar Harbor, ME | 📅 Sept. 10 – 16
Space is limited. 🔗 www.jax.org/education-an...
#AACR26
Expert-led lectures, hands-on training and personalized mentoring in the lab.
📍 Bar Harbor, ME | 📅 Sept. 10 – 16
Space is limited. 🔗 www.jax.org/education-an...
#AACR26